Table 1.
Clinical characteristics of patients presenting for transcatheter aortic valve implantation.
| Transfemoral | Transapical | Transaxillary | P value | |
|---|---|---|---|---|
| Patients | 107 | 15 | 15 | |
| Edwards-Sapien, n (%) | 61 (57) | 15 (100) | 3 (20) | <.0001 |
| CoreValve, n (%) | 46 (43) | 12 (80) | <.0001 | |
| Age (years) | 79.7 ± 7 | 78.8 ± 6.5 | 78.7 ± 5 | .794 |
| Male, n (%) | 56 (52) | 5 (33) | 12 (80) | .034 |
| Diabetes, n (%) | 31 (29) | 4 (26.7) | 5 (33) | .917 |
| Chronic kidney disease, n (%) | 39 (36.4) | 5 (33) | 7 (46.7) | .706 |
| Porcelain aorta, n (%) | 17 (15.9) | 14 (93.3) | 7 (46.7) | <.0001 |
| COPD, n (%) | 46 (43) | 6 (40) | 11 (73) | .077 |
| Previous myocardial infarction, n (%) | 29 (27) | 5 (33) | 6 (40) | .549 |
| Cerebrovascular disease, n (%) | 20 (18.7) | 8 (53) | 3 (20) | .011 |
| Peripheral vascular disease, n (%) | 26 (24.3) | 10 (67.7) | 12 (80) | <.0001 |
| NYHA functional class III-IV, n (%) | 75 (70) | 11 (73.3) | 9 (60) | .685 |
| Logistic EuroSCORE, mean ± SD | 26.6 ± 16 | 32.2 ± 23 | 28.6 ± 14 | .477 |
| STS-PROM score, mean ± SD | 7 ± 4.9 | 8.3 ± 4.2 | 6.9 ± 2.8 | .602 |
| Mean aortic gradient (mmHg), mean ± SD | 54 ± 17.2 | 44.7 ± 18 | 47.7 ± 14.9 | .074 |
| LVEF (%), mean ± SD | 50.8 ± 12.9 | 50 ± 12.5 | 52.8 ± 11 | .814 |
COPD: chronic obstructive pulmonary disease; NYHA: New York Heart Association; LVEF: left ventricle ejection fraction.